GSK said it will use its established manufacturing network in Belgium to support production. The companies will also work together to research, develop and manufacture several mRNA vaccine ...

GlaxoSmithKline Pharma Limited was incorporated in November 13, 1924. During year 1956, the Company began primary production of vaccines at ... product of UCB Pharma (Belgium) was launched under ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...

Belgium-based Agomab will use some of the proceeds ... 3 development of its novel group B streptococcus (GBS) preventative vaccine, currently in a pair of phase 2 trials, in pregnant women.

The vaccines studied, Zostavax and Shingrix, both appeared to offer protection. Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its ...

PHILADELPHIA, PA — The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told ...

and inactivated trivalent influenza vaccine (TIV; Fluarix™, GlaxoSmithKline Vaccines) in primed and unprimed cohorts of children aged from 18 to 47 months. The main aim of the study was to ...